epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Neffy

epinephrine nasal

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  SPRAY: 2 mg per actuation

anaphylaxis

[>30 kg]
Dose: 2 mg intranasally x1; Info: may repeat dose x1 in same nostril after 5min

renal dosing

[see below]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  SPRAY: 1 mg per actuation, 2 mg per actuation

anaphylaxis

[15-29 kg]
Dose: 1 mg intranasally x1; Info: may repeat dose x1 in same nostril after 5min
[>30 kg]
Dose: 2 mg intranasally x1; Info: may repeat dose x1 in same nostril after 5min

renal dosing

[see below]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[not defined]

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@2acc699c
  • IV use (auto-injector form)
  • caution: hypersensitivity to drug or ingredient
  • caution: hypersensitivity to sulfites
  • caution: elderly patients
  • caution: renal impairment
  • caution: HTN
  • caution: CAD
  • caution: cardiomyopathy
  • caution: arrhythmia
  • caution: cerebrovascular disease
  • caution: hyperthyroidism
  • caution: diabetes mellitus
  • caution: Parkinson disease
  • caution: psychiatric disorder
  • caution: nasal condition, structural (nasal use)
  • caution: nasal condition, anatomical (nasal use)

Drug Interactions .

Overview

epinephrine

alpha/beta agonist

Interaction Characteristics:
  • COMT substrate
  • hyperglycemic effects
  • hypertensive effects
  • hypokalemia
  • tachycardia
Other Info
  • nasal epinephrine use: caution advised with nasal drugs, including subsequent nasal epinephrine doses, up to 2 wk after initial administration; nasal epinephrine may incr. systemic absorption of nasal drugs, risk of adverse effects

Contraindicated

  • dihydroergotamine
  • Neffy (epinephrine nasal)
    +
    dihydroergotamine
    1 interaction

    Contraindicated

    epinephrine + dihydroergotamine

    contraindicated: combo may incr. risk of severe HTN, vasospasm, ischemia (synergistic effects)

  • phenelzine
  • Neffy (epinephrine nasal)
    +
    phenelzine
    1 interaction

    Contraindicated

    epinephrine + phenelzine

    contraindicated: combo may incr. risk of severe, prolonged HTN (additive effects)

Avoid/Use Alternative

  • amitriptyline
  • Neffy (epinephrine nasal)
    +
    amitriptyline
    2 interactions

    Avoid/Use Alternative

    epinephrine + amitriptyline

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

  • amoxapine
  • Neffy (epinephrine nasal)
    +
    amoxapine
    1 interaction

    Avoid/Use Alternative

    epinephrine + amoxapine

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

  • arsenic trioxide
  • Neffy (epinephrine nasal)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    epinephrine + arsenic trioxide

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • chlorpromazine
  • Neffy (epinephrine nasal)
    +
    chlorpromazine
    2 interactions

    Avoid/Use Alternative

    epinephrine + chlorpromazine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • clozapine
  • Neffy (epinephrine nasal)
    +
    clozapine
    2 interactions

    Avoid/Use Alternative

    epinephrine + clozapine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • cocaine
  • Neffy (epinephrine nasal)
    +
    cocaine
    1 interaction

    Avoid/Use Alternative

    epinephrine + cocaine

    use alternative or monitor BP, HR, ECG: combo may incr. risk of severe vasoconstriction, HTN, tachycardia, arrhythmias (additive effects)

  • desipramine
  • Neffy (epinephrine nasal)
    +
    desipramine
    2 interactions

    Avoid/Use Alternative

    epinephrine + desipramine

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

  • dronabinol
  • Neffy (epinephrine nasal)
    +
    dronabinol
    2 interactions

    Avoid/Use Alternative

    epinephrine + dronabinol

    avoid combo: combo may incr. risk of HTN, tachycardia (additive effects)

  • ephedra
  • Neffy (epinephrine nasal)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    epinephrine + ephedra

    avoid combo: combo may incr. risk of HTN, tachycardia (additive effects)

  • esmolol
  • Neffy (epinephrine nasal)
    +
    esmolol
    2 interactions

    Avoid/Use Alternative

    epinephrine + esmolol

    use alternative or monitor BP, HR: combo may decr. efficacy of both drugs (antagonistic effects)

  • fluphenazine
  • Neffy (epinephrine nasal)
    +
    fluphenazine
    1 interaction

    Avoid/Use Alternative

    epinephrine + fluphenazine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • formoterol inhaled
  • Neffy (epinephrine nasal)
    +
    formoterol inhaled
    2 interactions

    Avoid/Use Alternative

    epinephrine + formoterol inhaled

    use alternative or monitor BP, HR, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • haloperidol
  • Neffy (epinephrine nasal)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    epinephrine + haloperidol

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • imipramine
  • Neffy (epinephrine nasal)
    +
    imipramine
    1 interaction

    Avoid/Use Alternative

    epinephrine + imipramine

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

  • isoproterenol
  • Neffy (epinephrine nasal)
    +
    isoproterenol
    1 interaction

    Avoid/Use Alternative

    epinephrine + isoproterenol

    avoid combo: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, tachycardia (additive effects)

  • labetalol
  • Neffy (epinephrine nasal)
    +
    labetalol
    1 interaction

    Avoid/Use Alternative

    epinephrine + labetalol

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • linezolid
  • Neffy (epinephrine nasal)
    +
    linezolid
    1 interaction

    Avoid/Use Alternative

    epinephrine + linezolid

    use alternative or monitor BP: combo may incr. risk of severe, prolonged HTN (additive effects)

  • methylergonovine
  • Neffy (epinephrine nasal)
    +
    methylergonovine
    2 interactions

    Avoid/Use Alternative

    epinephrine + methylergonovine

    consider alternative or monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (synergistic effects)

  • nadolol
  • Neffy (epinephrine nasal)
    +
    nadolol
    1 interaction

    Avoid/Use Alternative

    epinephrine + nadolol

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • nortriptyline
  • Neffy (epinephrine nasal)
    +
    nortriptyline
    2 interactions

    Avoid/Use Alternative

    epinephrine + nortriptyline

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

  • ozanimod
  • Neffy (epinephrine nasal)
    +
    ozanimod
    1 interaction

    Avoid/Use Alternative

    epinephrine + ozanimod

    use alternative or monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • perphenazine
  • Neffy (epinephrine nasal)
    +
    perphenazine
    1 interaction

    Avoid/Use Alternative

    epinephrine + perphenazine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • pimozide
  • Neffy (epinephrine nasal)
    +
    pimozide
    2 interactions

    Avoid/Use Alternative

    epinephrine + pimozide

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • pindolol
  • Neffy (epinephrine nasal)
    +
    pindolol
    1 interaction

    Avoid/Use Alternative

    epinephrine + pindolol

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • procarbazine
  • Neffy (epinephrine nasal)
    +
    procarbazine
    1 interaction

    Avoid/Use Alternative

    epinephrine + procarbazine

    use alternative or monitor BP: combo may incr. risk of severe, prolonged HTN (additive effects)

  • promethazine
  • Neffy (epinephrine nasal)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    epinephrine + promethazine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • protriptyline
  • Neffy (epinephrine nasal)
    +
    protriptyline
    1 interaction

    Avoid/Use Alternative

    epinephrine + protriptyline

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

  • rasagiline
  • Neffy (epinephrine nasal)
    +
    rasagiline
    1 interaction

    Avoid/Use Alternative

    epinephrine + rasagiline

    use alternative or monitor BP: combo may incr. risk of severe, prolonged HTN (additive effects)

  • selegiline
  • Neffy (epinephrine nasal)
    +
    selegiline
    1 interaction

    Avoid/Use Alternative

    epinephrine + selegiline

    use alternative or monitor BP: combo may incr. risk of severe, prolonged HTN (additive effects)

  • thioridazine
  • Neffy (epinephrine nasal)
    +
    thioridazine
    1 interaction

    Avoid/Use Alternative

    epinephrine + thioridazine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • timolol
  • Neffy (epinephrine nasal)
    +
    timolol
    1 interaction

    Avoid/Use Alternative

    epinephrine + timolol

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • trifluoperazine
  • Neffy (epinephrine nasal)
    +
    trifluoperazine
    1 interaction

    Avoid/Use Alternative

    epinephrine + trifluoperazine

    use alternative or monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • yohimbe
  • Neffy (epinephrine nasal)
    +
    yohimbe
    1 interaction

    Avoid/Use Alternative

    epinephrine + yohimbe

    use alternative or monitor BP, HR: combo may incr. risk of severe, prolonged HTN, tachycardia (additive effects)

Monitor/Modify Tx

  • abiraterone acetate
  • Neffy (epinephrine nasal)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    epinephrine + abiraterone acetate

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • acarbose
  • Neffy (epinephrine nasal)
    +
    acarbose
    2 interactions

    Monitor/Modify Tx

    epinephrine + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • Neffy (epinephrine nasal)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    epinephrine + acebutolol

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • acetazolamide
  • Neffy (epinephrine nasal)
    +
    acetazolamide
    1 interaction

    Monitor/Modify Tx

    epinephrine + acetazolamide

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • albuterol inhaled
  • Neffy (epinephrine nasal)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    epinephrine + albuterol inhaled

    monitor potassium, ECG, BP, HR: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • aliskiren
  • Neffy (epinephrine nasal)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    epinephrine + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Neffy (epinephrine nasal)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    epinephrine + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aloe
  • Neffy (epinephrine nasal)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    epinephrine + aloe

    monitor potassium, ECG w/ aloe laxative doses: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • alogliptin
  • Neffy (epinephrine nasal)
    +
    alogliptin
    2 interactions

    Monitor/Modify Tx

    epinephrine + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • amiloride
  • Neffy (epinephrine nasal)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    epinephrine + amiloride

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • aminophylline
  • Neffy (epinephrine nasal)
    +
    aminophylline
    1 interaction

    Monitor/Modify Tx

    epinephrine + aminophylline

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • amiodarone
  • Neffy (epinephrine nasal)
    +
    amiodarone
    1 interaction

    Monitor/Modify Tx

    epinephrine + amiodarone

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • amlodipine
  • Neffy (epinephrine nasal)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphetamine
  • Neffy (epinephrine nasal)
    +
    amphetamine
    2 interactions

    Monitor/Modify Tx

    epinephrine + amphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • amphotericin
  • Neffy (epinephrine nasal)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    epinephrine + amphotericin

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • angiotensin II
  • Neffy (epinephrine nasal)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    epinephrine + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Neffy (epinephrine nasal)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    epinephrine + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Neffy (epinephrine nasal)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    epinephrine + arformoterol inhaled

    monitor potassium, ECG, BP, HR: combo may incr. risk of HTN, tachycardia, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • armodafinil
  • Neffy (epinephrine nasal)
    +
    armodafinil
    2 interactions

    Monitor/Modify Tx

    epinephrine + armodafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • asciminib
  • Neffy (epinephrine nasal)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    epinephrine + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asparaginase
  • Neffy (epinephrine nasal)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    epinephrine + asparaginase

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • atenolol
  • Neffy (epinephrine nasal)
    +
    atenolol
    2 interactions

    Monitor/Modify Tx

    epinephrine + atenolol

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • atogepant
  • Neffy (epinephrine nasal)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    epinephrine + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atomoxetine
  • Neffy (epinephrine nasal)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    epinephrine + atomoxetine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • atropine
  • Neffy (epinephrine nasal)
    +
    atropine
    1 interaction

    Monitor/Modify Tx

    epinephrine + atropine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • atropine ophthalmic
  • Neffy (epinephrine nasal)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    epinephrine + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Neffy (epinephrine nasal)
    +
    axitinib
    2 interactions

    Monitor/Modify Tx

    epinephrine + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Neffy (epinephrine nasal)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    epinephrine + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Neffy (epinephrine nasal)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    epinephrine + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Neffy (epinephrine nasal)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + benzphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • benztropine
  • Neffy (epinephrine nasal)
    +
    benztropine
    1 interaction

    Monitor/Modify Tx

    epinephrine + benztropine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • betamethasone
  • Neffy (epinephrine nasal)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    epinephrine + betamethasone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • betaxolol
  • Neffy (epinephrine nasal)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    epinephrine + betaxolol

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • bevacizumab
  • Neffy (epinephrine nasal)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bexagliflozin
  • Neffy (epinephrine nasal)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    epinephrine + bexagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bismuth subsalicylate
  • Neffy (epinephrine nasal)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    epinephrine + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Neffy (epinephrine nasal)
    +
    bisoprolol
    2 interactions

    Monitor/Modify Tx

    epinephrine + bisoprolol

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • brigatinib
  • Neffy (epinephrine nasal)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bromocriptine
  • Neffy (epinephrine nasal)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    epinephrine + bromocriptine

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • brompheniramine
  • Neffy (epinephrine nasal)
    +
    brompheniramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + brompheniramine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • budesonide
  • Neffy (epinephrine nasal)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    epinephrine + budesonide

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • bumetanide
  • Neffy (epinephrine nasal)
    +
    bumetanide
    2 interactions

    Monitor/Modify Tx

    epinephrine + bumetanide

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • bupropion
  • Neffy (epinephrine nasal)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    epinephrine + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cabozantinib
  • Neffy (epinephrine nasal)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Neffy (epinephrine nasal)
    +
    caffeine
    2 interactions

    Monitor/Modify Tx

    epinephrine + caffeine

    monitor BP, HR; avoid excessive caffeine intake: combo may incr. risk of HTN, tachycardia (additive effects)

  • caffeine citrate
  • Neffy (epinephrine nasal)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    epinephrine + caffeine citrate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • canagliflozin
  • Neffy (epinephrine nasal)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    epinephrine + canagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • candesartan cilexetil
  • Neffy (epinephrine nasal)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    epinephrine + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Neffy (epinephrine nasal)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    epinephrine + cannabis

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • captopril
  • Neffy (epinephrine nasal)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    epinephrine + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carbinoxamine
  • Neffy (epinephrine nasal)
    +
    carbinoxamine
    2 interactions

    Monitor/Modify Tx

    epinephrine + carbinoxamine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • carfilzomib
  • Neffy (epinephrine nasal)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    epinephrine + carfilzomib

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • celecoxib
  • Neffy (epinephrine nasal)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    epinephrine + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cetuximab
  • Neffy (epinephrine nasal)
    +
    cetuximab
    1 interaction

    Monitor/Modify Tx

    epinephrine + cetuximab

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • chlorothiazide
  • Neffy (epinephrine nasal)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    epinephrine + chlorothiazide

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • chlorpheniramine
  • Neffy (epinephrine nasal)
    +
    chlorpheniramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + chlorpheniramine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • chlorthalidone
  • Neffy (epinephrine nasal)
    +
    chlorthalidone
    2 interactions

    Monitor/Modify Tx

    epinephrine + chlorthalidone

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • cisplatin
  • Neffy (epinephrine nasal)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    epinephrine + cisplatin

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • clemastine
  • Neffy (epinephrine nasal)
    +
    clemastine
    1 interaction

    Monitor/Modify Tx

    epinephrine + clemastine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • clevidipine
  • Neffy (epinephrine nasal)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clonidine
  • Neffy (epinephrine nasal)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    epinephrine + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • colesevelam
  • Neffy (epinephrine nasal)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    epinephrine + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • copanlisib
  • Neffy (epinephrine nasal)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    epinephrine + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Neffy (epinephrine nasal)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    epinephrine + corticotropin

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • cortisone
  • Neffy (epinephrine nasal)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    epinephrine + cortisone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • crizotinib
  • Neffy (epinephrine nasal)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + crizotinib

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • cyclosporine
  • Neffy (epinephrine nasal)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    epinephrine + cyclosporine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyproheptadine
  • Neffy (epinephrine nasal)
    +
    cyproheptadine
    1 interaction

    Monitor/Modify Tx

    epinephrine + cyproheptadine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • danazol
  • Neffy (epinephrine nasal)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    epinephrine + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dapagliflozin
  • Neffy (epinephrine nasal)
    +
    dapagliflozin
    2 interactions

    Monitor/Modify Tx

    epinephrine + dapagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darbepoetin alfa
  • Neffy (epinephrine nasal)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    epinephrine + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • decitabine
  • Neffy (epinephrine nasal)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    epinephrine + decitabine

    monitor potassium, ECG w/ IV decitabine use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • deflazacort
  • Neffy (epinephrine nasal)
    +
    deflazacort
    2 interactions

    Monitor/Modify Tx

    epinephrine + deflazacort

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • desflurane
  • Neffy (epinephrine nasal)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    epinephrine + desflurane

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • desvenlafaxine
  • Neffy (epinephrine nasal)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    epinephrine + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Neffy (epinephrine nasal)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    epinephrine + dexamethasone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • dexbrompheniramine
  • Neffy (epinephrine nasal)
    +
    dexbrompheniramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + dexbrompheniramine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • dexchlorpheniramine
  • Neffy (epinephrine nasal)
    +
    dexchlorpheniramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + dexchlorpheniramine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • dexmethylphenidate
  • Neffy (epinephrine nasal)
    +
    dexmethylphenidate
    2 interactions

    Monitor/Modify Tx

    epinephrine + dexmethylphenidate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • dextroamphetamine
  • Neffy (epinephrine nasal)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + dextroamphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • dichlorphenamide
  • Neffy (epinephrine nasal)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    epinephrine + dichlorphenamide

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • diclofenac
  • Neffy (epinephrine nasal)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    epinephrine + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Neffy (epinephrine nasal)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    epinephrine + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dicyclomine
  • Neffy (epinephrine nasal)
    +
    dicyclomine
    1 interaction

    Monitor/Modify Tx

    epinephrine + dicyclomine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • diethylpropion
  • Neffy (epinephrine nasal)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    epinephrine + diethylpropion

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • diflunisal
  • Neffy (epinephrine nasal)
    +
    diflunisal
    2 interactions

    Monitor/Modify Tx

    epinephrine + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • digoxin
  • Neffy (epinephrine nasal)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    epinephrine + digoxin

    monitor ECG, electrolytes: combo may incr. risk of digoxin toxicity, cardiac arrhythmias (electrolyte abnormalities may incr. digoxin sensitivity)

  • diltiazem
  • Neffy (epinephrine nasal)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    epinephrine + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dimenhydrinate
  • Neffy (epinephrine nasal)
    +
    dimenhydrinate
    1 interaction

    Monitor/Modify Tx

    epinephrine + dimenhydrinate

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • dinutuximab
  • Neffy (epinephrine nasal)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    epinephrine + dinutuximab

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • diphenhydramine
  • Neffy (epinephrine nasal)
    +
    diphenhydramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + diphenhydramine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • disopyramide
  • Neffy (epinephrine nasal)
    +
    disopyramide
    1 interaction

    Monitor/Modify Tx

    epinephrine + disopyramide

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • dobutamine
  • Neffy (epinephrine nasal)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + dobutamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • dofetilide
  • Neffy (epinephrine nasal)
    +
    dofetilide
    1 interaction

    Monitor/Modify Tx

    epinephrine + dofetilide

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • dopamine
  • Neffy (epinephrine nasal)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + dopamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • doxapram
  • Neffy (epinephrine nasal)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    epinephrine + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Neffy (epinephrine nasal)
    +
    doxazosin
    2 interactions

    Monitor/Modify Tx

    epinephrine + doxazosin

    monitor BP: combo may decr. antihypertensive efficacy (antagonistic effects)

  • doxylamine
  • Neffy (epinephrine nasal)
    +
    doxylamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + doxylamine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • dronedarone
  • Neffy (epinephrine nasal)
    +
    dronedarone
    1 interaction

    Monitor/Modify Tx

    epinephrine + dronedarone

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • droxidopa
  • Neffy (epinephrine nasal)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    epinephrine + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • dulaglutide
  • Neffy (epinephrine nasal)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    epinephrine + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • eletriptan
  • Neffy (epinephrine nasal)
    +
    eletriptan
    2 interactions

    Monitor/Modify Tx

    epinephrine + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • emapalumab
  • Neffy (epinephrine nasal)
    +
    emapalumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + emapalumab

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • empagliflozin
  • Neffy (epinephrine nasal)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    epinephrine + empagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • enalapril
  • Neffy (epinephrine nasal)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    epinephrine + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Neffy (epinephrine nasal)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    epinephrine + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • entacapone
  • Neffy (epinephrine nasal)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    epinephrine + entacapone

    monitor BP, HR, ECG: combo may incr. epinephrine levels, risk of HTN, tachycardia, cardiac arrhythmias, other adverse effects (COMT metabolism inhibited)

  • ephedrine injection
  • Neffy (epinephrine nasal)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    epinephrine + ephedrine injection

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • ephedrine oral
  • Neffy (epinephrine nasal)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    epinephrine + ephedrine oral

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • eplerenone
  • Neffy (epinephrine nasal)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    epinephrine + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Neffy (epinephrine nasal)
    +
    epoetin alfa
    2 interactions

    Monitor/Modify Tx

    epinephrine + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eptinezumab
  • Neffy (epinephrine nasal)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Neffy (epinephrine nasal)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ertugliflozin
  • Neffy (epinephrine nasal)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    epinephrine + ertugliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • esketamine
  • Neffy (epinephrine nasal)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estetrol (contraceptive)
  • Neffy (epinephrine nasal)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    epinephrine + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Neffy (epinephrine nasal)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    epinephrine + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Neffy (epinephrine nasal)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    epinephrine + ethacrynic acid

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • ethanol (alcoholic beverage)
  • Neffy (epinephrine nasal)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    epinephrine + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Neffy (epinephrine nasal)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    epinephrine + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Neffy (epinephrine nasal)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    epinephrine + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Neffy (epinephrine nasal)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    epinephrine + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • exenatide
  • Neffy (epinephrine nasal)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    epinephrine + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • felodipine
  • Neffy (epinephrine nasal)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Neffy (epinephrine nasal)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Neffy (epinephrine nasal)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    epinephrine + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Neffy (epinephrine nasal)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    epinephrine + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Neffy (epinephrine nasal)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    epinephrine + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flecainide
  • Neffy (epinephrine nasal)
    +
    flecainide
    1 interaction

    Monitor/Modify Tx

    epinephrine + flecainide

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • fludrocortisone
  • Neffy (epinephrine nasal)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    epinephrine + fludrocortisone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • flurbiprofen
  • Neffy (epinephrine nasal)
    +
    flurbiprofen
    2 interactions

    Monitor/Modify Tx

    epinephrine + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • foscarnet
  • Neffy (epinephrine nasal)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    epinephrine + foscarnet

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • fosfomycin injection
  • Neffy (epinephrine nasal)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    epinephrine + fosfomycin injection

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • fosinopril
  • Neffy (epinephrine nasal)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    epinephrine + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Neffy (epinephrine nasal)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Neffy (epinephrine nasal)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Neffy (epinephrine nasal)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    epinephrine + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Neffy (epinephrine nasal)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • galcanezumab
  • Neffy (epinephrine nasal)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • glimepiride
  • Neffy (epinephrine nasal)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    epinephrine + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Neffy (epinephrine nasal)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    epinephrine + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Neffy (epinephrine nasal)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    epinephrine + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glycopyrrolate
  • Neffy (epinephrine nasal)
    +
    glycopyrrolate
    1 interaction

    Monitor/Modify Tx

    epinephrine + glycopyrrolate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • guanfacine
  • Neffy (epinephrine nasal)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    epinephrine + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Neffy (epinephrine nasal)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    epinephrine + hoodia

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • hydralazine
  • Neffy (epinephrine nasal)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    epinephrine + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Neffy (epinephrine nasal)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    epinephrine + hydrochlorothiazide

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • hydrocortisone
  • Neffy (epinephrine nasal)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    epinephrine + hydrocortisone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • hydroxocobalamin IV
  • Neffy (epinephrine nasal)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    epinephrine + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxyzine
  • Neffy (epinephrine nasal)
    +
    hydroxyzine
    1 interaction

    Monitor/Modify Tx

    epinephrine + hydroxyzine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • hyoscyamine
  • Neffy (epinephrine nasal)
    +
    hyoscyamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + hyoscyamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ibrutinib
  • Neffy (epinephrine nasal)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Neffy (epinephrine nasal)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    epinephrine + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibutilide
  • Neffy (epinephrine nasal)
    +
    ibutilide
    1 interaction

    Monitor/Modify Tx

    epinephrine + ibutilide

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • indapamide
  • Neffy (epinephrine nasal)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    epinephrine + indapamide

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • indomethacin
  • Neffy (epinephrine nasal)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    epinephrine + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • insulin
  • Neffy (epinephrine nasal)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    epinephrine + insulin

    monitor glucose, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. antidiabetic agent efficacy (additive effects, antagonistic effects)

  • irbesartan
  • Neffy (epinephrine nasal)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    epinephrine + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isoflurane
  • Neffy (epinephrine nasal)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    epinephrine + isoflurane

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • isosorbide dinitrate
  • Neffy (epinephrine nasal)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    epinephrine + isosorbide dinitrate

    monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • isosorbide mononitrate
  • Neffy (epinephrine nasal)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    epinephrine + isosorbide mononitrate

    monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • isradipine
  • Neffy (epinephrine nasal)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Neffy (epinephrine nasal)
    +
    ketamine
    2 interactions

    Monitor/Modify Tx

    epinephrine + ketamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other sympathomimetic adverse effects (additive effects)

  • ketoprofen
  • Neffy (epinephrine nasal)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    epinephrine + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Neffy (epinephrine nasal)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    epinephrine + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lanreotide
  • Neffy (epinephrine nasal)
    +
    lanreotide
    2 interactions

    Monitor/Modify Tx

    epinephrine + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Neffy (epinephrine nasal)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    epinephrine + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenalidomide
  • Neffy (epinephrine nasal)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    epinephrine + lenalidomide

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • lenvatinib
  • Neffy (epinephrine nasal)
    +
    lenvatinib
    2 interactions

    Monitor/Modify Tx

    epinephrine + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Neffy (epinephrine nasal)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    epinephrine + levalbuterol inhaled

    monitor potassium, ECG, BP, HR: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • levomilnacipran
  • Neffy (epinephrine nasal)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    epinephrine + levomilnacipran

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • levothyroxine
  • Neffy (epinephrine nasal)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    epinephrine + levothyroxine

    monitor BP, HR, ECG: combo may incr. risk of HTN, tachycardia, cardiac arrhythmias (additive effects)

  • licorice
  • Neffy (epinephrine nasal)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    epinephrine + licorice

    monitor BP, potassium, ECG w/ large amounts of licorice: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • lidocaine
  • Neffy (epinephrine nasal)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    epinephrine + lidocaine

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • lifileucel
  • Neffy (epinephrine nasal)
    +
    lifileucel
    2 interactions

    Monitor/Modify Tx

    epinephrine + lifileucel

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • linagliptin
  • Neffy (epinephrine nasal)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    epinephrine + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liothyronine
  • Neffy (epinephrine nasal)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    epinephrine + liothyronine

    monitor BP, HR, ECG: combo may incr. risk of HTN, tachycardia, cardiac arrhythmias (additive effects)

  • liraglutide
  • Neffy (epinephrine nasal)
    +
    liraglutide
    2 interactions

    Monitor/Modify Tx

    epinephrine + liraglutide

    monitor HR, glucose in type 2 diabetes mellitus pts: combo may incr. risk of tachycardia; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • lisdexamfetamine
  • Neffy (epinephrine nasal)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + lisdexamfetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • lisinopril
  • Neffy (epinephrine nasal)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    epinephrine + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lixisenatide
  • Neffy (epinephrine nasal)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    epinephrine + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorlatinib
  • Neffy (epinephrine nasal)
    +
    lorlatinib
    2 interactions

    Monitor/Modify Tx

    epinephrine + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Neffy (epinephrine nasal)
    +
    losartan
    2 interactions

    Monitor/Modify Tx

    epinephrine + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Neffy (epinephrine nasal)
    +
    lumacaftor/ ivacaftor
    2 interactions

    Monitor/Modify Tx

    epinephrine + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • luspatercept
  • Neffy (epinephrine nasal)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    epinephrine + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium citrate
  • Neffy (epinephrine nasal)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    epinephrine + magnesium citrate

    monitor potassium, ECG if magnesium citrate bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • magnesium salicylate
  • Neffy (epinephrine nasal)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    epinephrine + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • mannitol
  • Neffy (epinephrine nasal)
    +
    mannitol
    1 interaction

    Monitor/Modify Tx

    epinephrine + mannitol

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • meclizine
  • Neffy (epinephrine nasal)
    +
    meclizine
    2 interactions

    Monitor/Modify Tx

    epinephrine + meclizine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • meclofenamate
  • Neffy (epinephrine nasal)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    epinephrine + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Neffy (epinephrine nasal)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    epinephrine + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Neffy (epinephrine nasal)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    epinephrine + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metformin
  • Neffy (epinephrine nasal)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    epinephrine + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methamphetamine
  • Neffy (epinephrine nasal)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + methamphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • methazolamide
  • Neffy (epinephrine nasal)
    +
    methazolamide
    1 interaction

    Monitor/Modify Tx

    epinephrine + methazolamide

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Neffy (epinephrine nasal)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    epinephrine + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methscopolamine
  • Neffy (epinephrine nasal)
    +
    methscopolamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + methscopolamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • methyldopa
  • Neffy (epinephrine nasal)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    epinephrine + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylprednisolone
  • Neffy (epinephrine nasal)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    epinephrine + methylprednisolone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • methyltestosterone
  • Neffy (epinephrine nasal)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    epinephrine + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Neffy (epinephrine nasal)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    epinephrine + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Neffy (epinephrine nasal)
    +
    metolazone
    2 interactions

    Monitor/Modify Tx

    epinephrine + metolazone

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • metoprolol
  • Neffy (epinephrine nasal)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    epinephrine + metoprolol

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • mexiletine
  • Neffy (epinephrine nasal)
    +
    mexiletine
    1 interaction

    Monitor/Modify Tx

    epinephrine + mexiletine

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • mifepristone
  • Neffy (epinephrine nasal)
    +
    mifepristone
    1 interaction

    Monitor/Modify Tx

    epinephrine + mifepristone

    monitor potassium, ECG if daily mifepristone use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • miglitol
  • Neffy (epinephrine nasal)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    epinephrine + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milnacipran
  • Neffy (epinephrine nasal)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    epinephrine + milnacipran

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • minoxidil
  • Neffy (epinephrine nasal)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    epinephrine + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Neffy (epinephrine nasal)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    epinephrine + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Neffy (epinephrine nasal)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    epinephrine + modafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • moexipril
  • Neffy (epinephrine nasal)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    epinephrine + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • motixafortide
  • Neffy (epinephrine nasal)
    +
    motixafortide
    1 interaction

    Monitor/Modify Tx

    epinephrine + motixafortide

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • nabumetone
  • Neffy (epinephrine nasal)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    epinephrine + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naproxen
  • Neffy (epinephrine nasal)
    +
    naproxen
    2 interactions

    Monitor/Modify Tx

    epinephrine + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Neffy (epinephrine nasal)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    epinephrine + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nateglinide
  • Neffy (epinephrine nasal)
    +
    nateglinide
    2 interactions

    Monitor/Modify Tx

    epinephrine + nateglinide

    monitor glucose; consider incr. nateglinide dose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • naxitamab
  • Neffy (epinephrine nasal)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    epinephrine + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Neffy (epinephrine nasal)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    epinephrine + nebivolol

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • necitumumab
  • Neffy (epinephrine nasal)
    +
    necitumumab
    2 interactions

    Monitor/Modify Tx

    epinephrine + necitumumab

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • nicardipine
  • Neffy (epinephrine nasal)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Neffy (epinephrine nasal)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nilotinib
  • Neffy (epinephrine nasal)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + nilotinib

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • nimodipine
  • Neffy (epinephrine nasal)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Neffy (epinephrine nasal)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    epinephrine + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Neffy (epinephrine nasal)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    epinephrine + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nitroglycerin
  • Neffy (epinephrine nasal)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    epinephrine + nitroglycerin

    monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • nitroprusside
  • Neffy (epinephrine nasal)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    epinephrine + nitroprusside

    monitor BP: combo may decr. or reverse pressor effects of epinephrine (antagonistic effects)

  • norepinephrine
  • Neffy (epinephrine nasal)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    epinephrine + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Neffy (epinephrine nasal)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Neffy (epinephrine nasal)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    epinephrine + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Neffy (epinephrine nasal)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    epinephrine + olodaterol inhaled

    monitor potassium, ECG, BP, HR: combo may incr. risk of HTN, tachycardia, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • opicapone
  • Neffy (epinephrine nasal)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    epinephrine + opicapone

    monitor BP, HR, ECG: combo may incr. epinephrine levels, risk of HTN, tachycardia, cardiac arrhythmias, other adverse effects (COMT metabolism inhibited)

  • orphenadrine
  • Neffy (epinephrine nasal)
    +
    orphenadrine
    1 interaction

    Monitor/Modify Tx

    epinephrine + orphenadrine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • osilodrostat
  • Neffy (epinephrine nasal)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    epinephrine + osilodrostat

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • oxaprozin
  • Neffy (epinephrine nasal)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    epinephrine + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Neffy (epinephrine nasal)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    epinephrine + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Neffy (epinephrine nasal)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    epinephrine + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • pamidronate
  • Neffy (epinephrine nasal)
    +
    pamidronate
    2 interactions

    Monitor/Modify Tx

    epinephrine + pamidronate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • panitumumab
  • Neffy (epinephrine nasal)
    +
    panitumumab
    1 interaction

    Monitor/Modify Tx

    epinephrine + panitumumab

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • pazopanib
  • Neffy (epinephrine nasal)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    epinephrine + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Neffy (epinephrine nasal)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    epinephrine + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Neffy (epinephrine nasal)
    +
    pexidartinib
    2 interactions

    Monitor/Modify Tx

    epinephrine + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phendimetrazine
  • Neffy (epinephrine nasal)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    epinephrine + phendimetrazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • pheniramine
  • Neffy (epinephrine nasal)
    +
    pheniramine
    1 interaction

    Monitor/Modify Tx

    epinephrine + pheniramine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • phenoxybenzamine
  • Neffy (epinephrine nasal)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + phenoxybenzamine

    monitor BP, HR: combo may incr. risk of hypotension, tachycardia (paradoxical effects, unopposed stimulation of beta receptors)

  • phentermine
  • Neffy (epinephrine nasal)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    epinephrine + phentermine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • phentolamine
  • Neffy (epinephrine nasal)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + phentolamine

    monitor BP, HR: combo may incr. risk of hypotension, tachycardia (paradoxical effects, unopposed stimulation of beta receptors)

  • phenylephrine
  • Neffy (epinephrine nasal)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    epinephrine + phenylephrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenylephrine injection
  • Neffy (epinephrine nasal)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    epinephrine + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Neffy (epinephrine nasal)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    epinephrine + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Neffy (epinephrine nasal)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    epinephrine + phenylephrine ophthalmic

    monitor BP, HR; risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenylephrine rectal
  • Neffy (epinephrine nasal)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    epinephrine + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pioglitazone
  • Neffy (epinephrine nasal)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    epinephrine + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • Neffy (epinephrine nasal)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    epinephrine + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • polyethylene glycol
  • Neffy (epinephrine nasal)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    epinephrine + polyethylene glycol

    monitor potassium, ECG if polyethylene glycol bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • ponatinib
  • Neffy (epinephrine nasal)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Neffy (epinephrine nasal)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    epinephrine + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • posaconazole
  • Neffy (epinephrine nasal)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    epinephrine + posaconazole

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • pramlintide
  • Neffy (epinephrine nasal)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    epinephrine + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Neffy (epinephrine nasal)
    +
    prazosin
    2 interactions

    Monitor/Modify Tx

    epinephrine + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Neffy (epinephrine nasal)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    epinephrine + prednisolone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • prednisone
  • Neffy (epinephrine nasal)
    +
    prednisone
    2 interactions

    Monitor/Modify Tx

    epinephrine + prednisone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • procainamide
  • Neffy (epinephrine nasal)
    +
    procainamide
    1 interaction

    Monitor/Modify Tx

    epinephrine + procainamide

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • propafenone
  • Neffy (epinephrine nasal)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    epinephrine + propafenone

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • pseudoephedrine
  • Neffy (epinephrine nasal)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    epinephrine + pseudoephedrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • pyrilamine
  • Neffy (epinephrine nasal)
    +
    pyrilamine
    1 interaction

    Monitor/Modify Tx

    epinephrine + pyrilamine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • quetiapine
  • Neffy (epinephrine nasal)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    epinephrine + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Neffy (epinephrine nasal)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    epinephrine + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quinidine (antiarrhythmic)
  • Neffy (epinephrine nasal)
    +
    quinidine (antiarrhythmic)
    2 interactions

    Monitor/Modify Tx

    epinephrine + quinidine (antiarrhythmic)

    monitor ECG: combo may incr. risk of cardiac arrhythmias (additive effects)

  • ramipril
  • Neffy (epinephrine nasal)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    epinephrine + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • regorafenib
  • Neffy (epinephrine nasal)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    epinephrine + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • repaglinide
  • Neffy (epinephrine nasal)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    epinephrine + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rimegepant
  • Neffy (epinephrine nasal)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    epinephrine + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Neffy (epinephrine nasal)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Neffy (epinephrine nasal)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    epinephrine + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Neffy (epinephrine nasal)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    epinephrine + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rosiglitazone
  • Neffy (epinephrine nasal)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    epinephrine + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Neffy (epinephrine nasal)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    epinephrine + rotigotine transdermal

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • sacituzumab govitecan
  • Neffy (epinephrine nasal)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    epinephrine + sacituzumab govitecan

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • salmeterol inhaled
  • Neffy (epinephrine nasal)
    +
    salmeterol inhaled
    2 interactions

    Monitor/Modify Tx

    epinephrine + salmeterol inhaled

    monitor potassium, ECG, BP, HR: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • salsalate
  • Neffy (epinephrine nasal)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    epinephrine + salsalate

    monitor BP w/ high-dose salsalate: combo may incr. risk of HTN (additive effects)

  • saxagliptin
  • Neffy (epinephrine nasal)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    epinephrine + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selinexor
  • Neffy (epinephrine nasal)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    epinephrine + selinexor

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • selpercatinib
  • Neffy (epinephrine nasal)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • semaglutide
  • Neffy (epinephrine nasal)
    +
    semaglutide
    2 interactions

    Monitor/Modify Tx

    epinephrine + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sevoflurane
  • Neffy (epinephrine nasal)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    epinephrine + sevoflurane

    monitor ECG, BP: combo may incr. risk of cardiac arrhythmias (additive effects)

  • siponimod
  • Neffy (epinephrine nasal)
    +
    siponimod
    2 interactions

    Monitor/Modify Tx

    epinephrine + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sirolimus albumin-bound
  • Neffy (epinephrine nasal)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    epinephrine + sirolimus albumin-bound

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sitagliptin
  • Neffy (epinephrine nasal)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    epinephrine + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium benzoate
  • Neffy (epinephrine nasal)
    +
    sodium benzoate
    1 interaction

    Monitor/Modify Tx

    epinephrine + sodium benzoate

    monitor potassium, ECG, especially if hyperammonemia use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium phenylacetate
  • Neffy (epinephrine nasal)
    +
    sodium phenylacetate
    1 interaction

    Monitor/Modify Tx

    epinephrine + sodium phenylacetate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium phenylbutyrate
  • Neffy (epinephrine nasal)
    +
    sodium phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    epinephrine + sodium phenylbutyrate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium polystyrene sulfonate
  • Neffy (epinephrine nasal)
    +
    sodium polystyrene sulfonate
    1 interaction

    Monitor/Modify Tx

    epinephrine + sodium polystyrene sulfonate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium thiosulfate
  • Neffy (epinephrine nasal)
    +
    sodium thiosulfate
    1 interaction

    Monitor/Modify Tx

    epinephrine + sodium thiosulfate

    if ototoxicity risk reduction use, monitor potassium, ECG; otherwise, caution advised: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • solriamfetol
  • Neffy (epinephrine nasal)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    epinephrine + solriamfetol

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • sorafenib
  • Neffy (epinephrine nasal)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    epinephrine + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sotalol
  • Neffy (epinephrine nasal)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    epinephrine + sotalol

    monitor BP, ECG: combo may incr. risk of cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • spironolactone
  • Neffy (epinephrine nasal)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    epinephrine + spironolactone

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • sulindac
  • Neffy (epinephrine nasal)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    epinephrine + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Neffy (epinephrine nasal)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    epinephrine + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Neffy (epinephrine nasal)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Neffy (epinephrine nasal)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    epinephrine + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tafasitamab
  • Neffy (epinephrine nasal)
    +
    tafasitamab
    2 interactions

    Monitor/Modify Tx

    epinephrine + tafasitamab

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • tagraxofusp
  • Neffy (epinephrine nasal)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    epinephrine + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Neffy (epinephrine nasal)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    epinephrine + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Neffy (epinephrine nasal)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    epinephrine + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Neffy (epinephrine nasal)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    epinephrine + terbutaline

    monitor potassium, ECG, BP, HR: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • teriflunomide
  • Neffy (epinephrine nasal)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    epinephrine + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Neffy (epinephrine nasal)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    epinephrine + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • theophylline
  • Neffy (epinephrine nasal)
    +
    theophylline
    1 interaction

    Monitor/Modify Tx

    epinephrine + theophylline

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • thyroid
  • Neffy (epinephrine nasal)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    epinephrine + thyroid

    monitor BP, HR, ECG: combo may incr. risk of HTN, tachycardia, cardiac arrhythmias (additive effects)

  • tirzepatide
  • Neffy (epinephrine nasal)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    epinephrine + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Neffy (epinephrine nasal)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    epinephrine + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolcapone
  • Neffy (epinephrine nasal)
    +
    tolcapone
    2 interactions

    Monitor/Modify Tx

    epinephrine + tolcapone

    monitor BP, HR, ECG: combo may incr. epinephrine levels, risk of HTN, tachycardia, cardiac arrhythmias, other adverse effects (COMT metabolism inhibited)

  • tolmetin
  • Neffy (epinephrine nasal)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    epinephrine + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • topiramate
  • Neffy (epinephrine nasal)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    epinephrine + topiramate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • torsemide
  • Neffy (epinephrine nasal)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    epinephrine + torsemide

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • trametinib
  • Neffy (epinephrine nasal)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    epinephrine + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Neffy (epinephrine nasal)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    epinephrine + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Neffy (epinephrine nasal)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    epinephrine + triamcinolone

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • triamterene
  • Neffy (epinephrine nasal)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    epinephrine + triamterene

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • triprolidine
  • Neffy (epinephrine nasal)
    +
    triprolidine
    1 interaction

    Monitor/Modify Tx

    epinephrine + triprolidine

    monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

  • trospium
  • Neffy (epinephrine nasal)
    +
    trospium
    1 interaction

    Monitor/Modify Tx

    epinephrine + trospium

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ubrogepant
  • Neffy (epinephrine nasal)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    epinephrine + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vadadustat
  • Neffy (epinephrine nasal)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    epinephrine + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Neffy (epinephrine nasal)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    epinephrine + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Neffy (epinephrine nasal)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    epinephrine + vamorolone

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • vandetanib
  • Neffy (epinephrine nasal)
    +
    vandetanib
    2 interactions

    Monitor/Modify Tx

    epinephrine + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Neffy (epinephrine nasal)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    epinephrine + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • Neffy (epinephrine nasal)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    epinephrine + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Neffy (epinephrine nasal)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    epinephrine + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Neffy (epinephrine nasal)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    epinephrine + vilanterol inhaled

    monitor potassium, ECG, BP, HR: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • viloxazine
  • Neffy (epinephrine nasal)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    epinephrine + viloxazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • voclosporin
  • Neffy (epinephrine nasal)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    epinephrine + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • Neffy (epinephrine nasal)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    epinephrine + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Neffy (epinephrine nasal)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    epinephrine + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Neffy (epinephrine nasal)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    epinephrine + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zonisamide
  • Neffy (epinephrine nasal)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    epinephrine + zonisamide

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@3e7b3eed
  • respiratory difficulty
  • pulmonary edema
  • HTN
  • arrhythmia
  • myocardial ischemia
  • stress cardiomyopathy
  • cerebral hemorrhage
  • renal impairment
  • tissue damage, extravasation-related (IV use)
  • myonecrosis (SC or IM use)
  • necrotizing fasciitis (SC or IM use)

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@361e2bc8
  • palpitations
  • tachycardia
  • respiratory difficulty
  • nausea
  • vomiting
  • pallor
  • diaphoresis
  • dizziness
  • weakness
  • tremor
  • headache
  • apprehension
  • nervousness
  • anxiety
  • restlessness
  • nasal discomfort (nasal use)
  • nasal congestion (nasal use)
  • rhinorrhea (nasal use)
  • paresthesia (nasal use)
  • epistaxis (nasal use)
  • throat irritation (nasal use)

Safety/Monitoring .

Monitoring Parameters
no routine tests recommended

Look/Sound-Alike Drug Names
EPINEPHrine confused with: ePHEDrine; Neo-Synephrine; norepinephrine; phenylephrine

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially during labor and delivery, though benefits outweigh risks for anaphylaxis use; possible risk of teratogenicity based on limited or conflicting human data; risk of teratogenicity and embryo-fetal death based on animal data at 3-15x MRHD; risk of decr. uterine perfusion and interference with uterine contractility based on drug's mechanism of action

Lactation

Clinical Summary

benefits outweigh risks while breastfeeding; no human data available, though risk of infant harm not expected based on drug properties; no human data available, though theoretical decr. milk production with high-dose IV use based on decr. prolactin levels

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@3ec8a7ed

Metabolism: for epinephrine: liver, other tissues; CYP450: unknown

Excretion: for epinephrine: urine (minimally unchanged); Half-life: <5min (IV)

Subclass: Anaphylaxis

Mechanism of Action
for epinephrine: stimulates alpha and beta adrenergic receptors (sympathomimetic)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: ARS Pharmaceuticals

com.epocrates.rxweb.beans.DrugOtherInfoBean@58549373

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information